Roffman Miller Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.1M Buy
264,026
+230
+0.1% +$53.6K 3.51% 7
2026
Q1
$64.5M Sell
263,796
-8,487
-3% -$1.98M 3.72% 5
2025
Q4
$56.3M Buy
272,283
+4,643
+2% +$918K 3.08% 8
2025
Q3
$49.6M Buy
267,640
+1,269
+0.5% +$217K 2.78% 10
2025
Q2
$40.7M Buy
266,371
+2,953
+1% +$454K 2.43% 15
2025
Q1
$43.7M Buy
263,418
+2,020
+0.8% +$316K 2.75% 14
2024
Q4
$37.8M Buy
261,398
+2,117
+0.8% +$328K 2.32% 16
2024
Q3
$42M Buy
259,281
+9,029
+4% +$1.44M 2.56% 14
2024
Q2
$36.6M Buy
250,252
+6,839
+3% +$1.02M 2.41% 15
2024
Q1
$38.5M Buy
243,413
+2,416
+1% +$385K 2.57% 15
2023
Q4
$37.8M Buy
240,997
+95
+0% +$14.6K 2.7% 13
2023
Q3
$37.5M Buy
240,902
+3,606
+2% +$595K 2.97% 11
2023
Q2
$39.3M Buy
237,296
+2,816
+1% +$454K 2.95% 11
2023
Q1
$36.3M Buy
234,480
+530
+0.2% +$85.6K 2.9% 11
2022
Q4
$41.3M Buy
233,950
+116
+0% +$20K 3.41% 6
2022
Q3
$38.2M Buy
233,834
+1,345
+0.6% +$228K 3.49% 7
2022
Q2
$41.3M Sell
232,489
-3,451
-1% -$615K 3.57% 4
2022
Q1
$41.8M Sell
235,940
-1,001
-0.4% -$170K 3.11% 7
2021
Q4
$40.5M Buy
236,941
+3,682
+2% +$603K 2.74% 11
2021
Q3
$37.7M Sell
233,259
-207,906
-47% -$35.5M 2.8% 10
2021
Q2
$38.1M Buy
441,165
+4,847
+1% +$802K 2.89% 9
2021
Q1
$37.5M Buy
436,318
+96,018
+28% +$15.5M 3.12% 10
2020
Q4
$35M Buy
340,300
+117,754
+53% +$17.4M 3.03% 12
2020
Q3
$33.1M Sell
222,546
-1,658
-0.7% -$245K 3.21% 8
2020
Q2
$31.5M Buy
224,204
+3,223
+1% +$470K 3.14% 7
2020
Q1
$29M Buy
220,981
+8,502
+4% +$1.21M 3.62% 4
2019
Q4
$31M Sell
212,479
-1,341
-0.6% -$182K 3.1% 10
2019
Q3
$27.7M Sell
213,820
-2,640
-1% -$348K 2.9% 16
2019
Q2
$30.1M Sell
216,460
-1,669
-0.8% -$231K 3.24% 10
2019
Q1
$30.5M Buy
218,129
+8,187
+4% +$1.1M 3.47% 6
2018
Q4
$27.1M Sell
209,942
-2,771
-1% -$387K 3.53% 5
2018
Q3
$29.4M Buy
212,713
+2,487
+1% +$330K 3.26% 8
2018
Q2
$25.5M Buy
210,226
+5,801
+3% +$724K 3.12% 9
2018
Q1
$26.2M Buy
204,425
+5,800
+3% +$784K 3.32% 6
2017
Q4
$27.8M Sell
198,625
-144
-0.1% -$20.1K 3.42% 6
2017
Q3
$25.8M Buy
198,769
+1,919
+1% +$254K 3.41% 5
2017
Q2
$26M Buy
196,850
+3,322
+2% +$424K 3.57% 3
2017
Q1
$24.1M Buy
193,528
+3,265
+2% +$390K 3.41% 5
2016
Q4
$21.9M Buy
190,263
+5,125
+3% +$592K 3.31% 4
2016
Q3
$21.9M Sell
185,138
-1,240
-0.7% -$150K 3.54% 2
2016
Q2
$22.6M Sell
186,378
-5,691
-3% -$647K 3.71% 1
2016
Q1
$20.8M Buy
192,069
+9,561
+5% +$990K 3.56% 2
2015
Q4
$18.7M Buy
182,508
+3,344
+2% +$336K 3.43% 3
2015
Q3
$16.7M Buy
179,164
+7,550
+4% +$730K 3.28% 4
2015
Q2
$16.7M Buy
171,614
+3,065
+2% +$307K 3.17% 5
2015
Q1
$17M Buy
168,549
+2,060
+1% +$209K 3.24% 5
2014
Q4
$17.4M Sell
166,489
-23
-0% -$2.42K 3.39% 2
2014
Q3
$17.7M Buy
166,512
+11,836
+8% +$1.23M 3.64% 1
2014
Q2
$16.2M Buy
154,676
+3,012
+2% +$304K 3.41% 1
2014
Q1
$14.9M Buy
151,664
+4,814
+3% +$446K 3.31% 1
2013
Q4
$13.4M Buy
146,850
+5,003
+4% +$461K 3.09% 4
2013
Q3
$12.3M Buy
141,847
+4,100
+3% +$368K 3.11% 1
2013
Q2
$11.8M Buy
+137,747
New +$11.7M 3.16% 1

Other funds holding JNJ

Roffman Miller Associates's JNJ Position: Q2 2026 in Review

Roffman Miller Associates increased its Johnson & Johnson (JNJ) stake by 0.09% in Q2 2026, buying an estimated $53.6K and bringing the position to 264,026 shares worth $67.1M. The position accounts for 3.51% of the portfolio, ranked #7.

Roffman Miller Associates first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Roffman Miller Associates held 264,026 shares of Johnson & Johnson worth $67.1M as of Q2 2026.
  • Roffman Miller Associates bought 230 Johnson & Johnson shares in Q2 2026, an estimated $53.6K.
  • Johnson & Johnson made up 3.51% of Roffman Miller Associates's portfolio in Q2 2026, its #7 holding.
  • Roffman Miller Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Roffman Miller Associates's 13F filing for Q2 2026, filed 13 Jul 2026.